Immix Biopharma, Inc.(IMMX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

IMMX Immix Biopharma, Inc.

Closed 09-22 16:00:00 EDT

12.83

+0.36

+2.89%

盘后12.83

+0.000.00%

19:31 EDT

High12.90	Low12.31	Vol948.50K
Open12.45	D1 Closing12.47	Amplitude4.73%
Mkt Cap913.37M	Tradable Cap754.24M	Total Shares71.19M
T/O11.96M	T/O Rate1.61%	Tradable Shares58.79M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"IMMX","market":"US","secType":"STK","nameCN":"Immix Biopharma, Inc.","latestPrice":12.83,"timestamp":1790107200000,"preClose":12.47,"halted":0,"volume":948503,"hourTrading":{"tag":"盘后","latestPrice":12.83,"preClose":12.83,"latestTime":"19:31 EDT","volume":14772,"amount":189516.9725,"timestamp":1790119915950,"change":0,"changeRate":0,"amplitude":0.000008},"delay":0,"changeRate":0.028869286287088968,"floatShares":58787133,"shares":71190000,"eps":-0.8667,"marketStatus":"Closed","change":0.36,"latestTime":"09-22 16:00:00 EDT","open":12.45,"high":12.9,"low":12.31,"amount":11957088.707822,"amplitude":0.047314,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.8667,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1790150400000},"marketStatusCode":5,"adr":0,"listingDate":1639630800000,"exchange":"NASDAQ","adjPreClose":12.47,"preHourTrading":{"tag":"盘前","latestPrice":12.26,"preClose":12.47,"latestTime":"09:24 EDT","volume":1701,"amount":21271.935447,"timestamp":1790083451217,"change":-0.21,"changeRate":-0.01684,"amplitude":0.063352},"postHourTrading":{"tag":"盘后","latestPrice":12.83,"preClose":12.83,"latestTime":"19:31 EDT","volume":14772,"amount":189516.9725,"timestamp":1790119915950,"change":0,"changeRate":0,"amplitude":0.000008},"volumeRatio":0.516838,"impliedVol":1.4057,"impliedVolPercentile":0.6773},"requestUrl":"/m/hq/s/IMMX","defaultTab":"news","newsList":[{"id":"2667960208","title":"Immix Biopharma, Inc. : Mizuho Raises Target Price to $26 from $15","url":"https://stock-news.laohu8.com/highlight/detail?id=2667960208","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667960208?lang=en_us&edition=fundamental","pubTime":"2026-09-16 18:39","pubTimestamp":1789555147,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nFWN4570M6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IMMX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667608922","title":"U.S. Research Roundup-Domino's, McDonald's, Starbucks","url":"https://stock-news.laohu8.com/highlight/detail?id=2667608922","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667608922?lang=en_us&edition=fundamental","pubTime":"2026-09-16 15:02","pubTimestamp":1789542132,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Domino's, McDonald's, StarbucksSept 16 (Reuters)-Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Domino's, McD","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nL4N4580E9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FCEL","DTM","PYZ","JBHT","CRM","FTAI","RYAN","ABNB","AWAY","RAPP","SLDB","EXPE","BKV","CCL","COPP","AVAV","ABNG","CMCSA","SHAK","CBZ","BKNG","GOLF","LEN","EMET","MTH","CMGG","QSR","IRON","MDST","FCX","SGDM","BROS","NEM","ABTC","CAVA","XAR","CTVA","FTAG","DHI","IMMX","KBH","PHM","DRI","RCUS","DPZ","MCD","CMG","SBUX","RGLD","AJG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667628810","title":"Immix Biopharma is Maintained at Outperform by Mizuho","url":"https://stock-news.laohu8.com/highlight/detail?id=2667628810","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667628810?lang=en_us&edition=fundamental","pubTime":"2026-09-15 21:52","pubTimestamp":1789480320,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/IMMX/analyst-ratings","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMMX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667445446","title":"Mizuho Raises Price Target on Immix Biopharma to $26 From $15, Keeps Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2667445446","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667445446?lang=en_us&edition=fundamental","pubTime":"2026-09-15 19:44","pubTimestamp":1789472673,"startTime":"0","endTime":"0","summary":"Immix Biopharma (IMMX) has an average rating of buy and mean price target of $22.29, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ban","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","IMMX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664213848","title":"Immix Biopharma Highlights NXC-201 CAR-T Data in Relapsed/refractory AL Amyloidosis Trial Presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=2664213848","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664213848?lang=en_us&edition=fundamental","pubTime":"2026-09-03 00:07","pubTimestamp":1788365274,"startTime":"0","endTime":"0","summary":"Immix Biopharma highlights NXC-201 CAR-T data in relapsed/refractory AL amyloidosis trial presentationImmix investor presentation highlighted NXC-201 BCMA CAR-T in relapsed/refractory AL amyloidosis, ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDL1Khd6G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMMX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658914539","title":"Immix Biopharma Price Target Cut to $19.00/Share from $20.00 by Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2658914539","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658914539?lang=en_us&edition=fundamental","pubTime":"2026-08-12 00:06","pubTimestamp":1786464360,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/IMMX/analyst-ratings","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IMMX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658961829","title":"Morgan Stanley Adjusts PT on Immix Biopharma to $19 From $20, Maintains Overweight Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2658961829","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658961829?lang=en_us&edition=fundamental","pubTime":"2026-08-11 17:31","pubTimestamp":1786440671,"startTime":"0","endTime":"0","summary":"Immix Biopharma (IMMX) has an average rating of buy and mean price target of $20.44, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ban","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IMMX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658568459","title":"Immix Biopharma Publishes Corporate Presentation on NXC-201 BCMA CAR-T in Relapsed/refractory AL Amyloidosis","url":"https://stock-news.laohu8.com/highlight/detail?id=2658568459","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658568459?lang=en_us&edition=fundamental","pubTime":"2026-08-11 03:31","pubTimestamp":1786390303,"startTime":"0","endTime":"0","summary":"Immix Biopharma publishes corporate presentation on NXC-201 BCMA CAR-T in relapsed/refractory AL amyloidosisImmix highlighted NXC-201, a BCMA-targeted CAR-T, as its lead program for relapsed or refrac","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nNDL83X1my:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IMMX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658936420","title":"Immix Biopharma is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2658936420","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658936420?lang=en_us&edition=fundamental","pubTime":"2026-08-10 20:19","pubTimestamp":1786364340,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/IMMX/analyst-ratings","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IMMX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658938304","title":"Analysts Are Bullish on These Healthcare Stocks: Immix Biopharma (IMMX), Ardelyx (ARDX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658938304","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658938304?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:00","pubTimestamp":1786359631,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Immix Biopharma (IMMX), Ardelyx (ARDX) and Structure...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-immix-biopharma-immx-ardelyx-ardx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-immix-biopharma-immx-ardelyx-ardx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARDX","IMMX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658198768","title":"Immix Biopharma, Inc. : H.c. Wainwright Raises Target Price to $25 from $20","url":"https://stock-news.laohu8.com/highlight/detail?id=2658198768","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658198768?lang=en_us&edition=fundamental","pubTime":"2026-08-10 18:17","pubTimestamp":1786357063,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nAZN4TCYZ2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IMMX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657621350","title":"Immix Biopharma, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2657621350","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657621350?lang=en_us&edition=fundamental","pubTime":"2026-08-08 05:46","pubTimestamp":1786139196,"startTime":"0","endTime":"0","summary":"Immix Biopharma, Inc. reports results for the quarter ended June 30 - Earnings SummaryImmix Biopharma, Inc.IMMX.OQreported a quarterly adjusted loss of 18 cents per share for the quarter ended June 30","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nL8N4442LT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMMX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657162990","title":"Immix Biopharma Q2 FY26 Net Loss Widens to USD 11.56 Million; G&A Expense More than Doubled to USD 7.12 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657162990","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657162990?lang=en_us&edition=fundamental","pubTime":"2026-08-08 05:06","pubTimestamp":1786136780,"startTime":"0","endTime":"0","summary":"Immix Biopharma Q2 FY26 net loss widens to USD 11.56 million; G&A expense more than doubled to USD 7.12 millionImmix Biopharma posted a net loss of USD 11.56 million for the quarter ended June 30, 202","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nNDL6kgjbr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IMMX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657424562","title":"Immix Biopharma, Inc. Expected to Post a Loss of 18 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2657424562","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657424562?lang=en_us&edition=fundamental","pubTime":"2026-08-05 04:55","pubTimestamp":1785876908,"startTime":"0","endTime":"0","summary":"Immix Biopharma, Inc. <IMMX.OQ> expected to post a loss of18cents a share - Earnings PreviewImmix Biopharma, Inc.IMMX.OQIMMX.Ois expected to  report resultson August 6 (estimated) for the period endin","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nL8N44132U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IMMX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656559030","title":"Immix Biopharma to Attend Morgan Stanley Global Healthcare Conference, Host Investor Meetings","url":"https://stock-news.laohu8.com/highlight/detail?id=2656559030","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656559030?lang=en_us&edition=fundamental","pubTime":"2026-08-04 21:15","pubTimestamp":1785849335,"startTime":"0","endTime":"0","summary":"Immix Biopharma to attend Morgan Stanley Global Healthcare Conference, host investor meetingsImmix Biopharma will participate in the Morgan Stanley 24th Annual Global Healthcare Conference in New York","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nNDL60MW0y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMMX","LU1162221912.USD","LU0210528500.USD","LU1064131342.USD","LU0234570918.USD","BK4139","LU2089284900.SGD","LU2210150020.SGD","BK4127","SG9999014005.SGD","LU1720051108.HKD","LU0314104364.USD","LU0557290698.USD","LU2210149790.SGD","BCDF","LU1732799900.SGD","LU0795875086.SGD","LU1074936037.SGD","LU0225283273.USD","LU1791710400.SGD","SG9999014039.USD","KBWB","BK4516","LU1791710582.SGD","LU0528227936.USD","LU0158827781.USD","BK4504","IAI","LU1244550221.USD","LU0158827948.USD","IE00B3QW5Z07.USD","LU2028103732.USD","BK4581","LU1668664300.SGD","SG9999014021.USD","IE00B64PRP62.GBP","IE00BKPKM429.USD","LU0098860793.USD","LU1244550577.SGD","IE00BN0W2T93.GBP","IE00BN0W2W23.USD","LU0882574139.USD","LU0912757837.SGD","LU2023251221.USD","NDAQ","LU0390134368.USD","BK4534","LU0320765646.SGD","LU1988902786.USD","IE00B3S45H60.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653752161","title":"Immix Biopharma Initiated at Buy by Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2653752161","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653752161?lang=en_us&edition=fundamental","pubTime":"2026-07-22 19:27","pubTimestamp":1784719620,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/IMMX/analyst-ratings(END) Dow Jones NewswiresJuly 22, 2026 07:27 ET","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IMMX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653752931","title":"Needham Initiates Immix Biopharma at Buy With $21 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2653752931","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653752931?lang=en_us&edition=fundamental","pubTime":"2026-07-22 19:19","pubTimestamp":1784719172,"startTime":"0","endTime":"0","summary":"Immix Biopharma (IMMX) has an average rating of buy and mean price target of $19.94, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ban","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IMMX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653275453","title":"Immix Biopharma Inc : Needham Initiates Coverage with Buy Rating; Target Price $21","url":"https://stock-news.laohu8.com/highlight/detail?id=2653275453","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653275453?lang=en_us&edition=fundamental","pubTime":"2026-07-22 18:58","pubTimestamp":1784717902,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nFWN43O0QS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","IMMX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652294716","title":"Immix Biopharma Terminates Richard Graydon Employment","url":"https://stock-news.laohu8.com/highlight/detail?id=2652294716","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652294716?lang=en_us&edition=fundamental","pubTime":"2026-07-20 18:06","pubTimestamp":1784542013,"startTime":"0","endTime":"0","summary":"Immix Biopharma terminates Richard Graydon employmentImmix Biopharma terminated Richard Graydon, effective July 17, 2026.Departure was described as unrelated to his activities at the company.Managemen","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260720:nNDL5w6tqH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IMMX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652795294","title":"Immix Biopharma - Richard Graydon Terminated from Immix Biopharma as of July 17, 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2652795294","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652795294?lang=en_us&edition=fundamental","pubTime":"2026-07-20 18:06","pubTimestamp":1784541967,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260720:nFWN43M04G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IMMX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.immixbio.com","stockEarnings":[{"period":"1week","weight":0.0213},{"period":"1month","weight":-0.0871},{"period":"3month","weight":0.2583},{"period":"6month","weight":0.3996},{"period":"1year","weight":4.6941},{"period":"ytd","weight":1.3843}],"compareEarnings":[{"period":"1week","weight":0.0166},{"period":"1month","weight":0.0102},{"period":"3month","weight":0.0544},{"period":"6month","weight":0.1776},{"period":"1year","weight":0.1654},{"period":"ytd","weight":0.1343}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in developing tissue-specific therapeutics in oncology and immune-dysregulated diseases in the United States and Australia. The company is developing IMX-110 that is in Phase 1b/2a clinical trials for the treatment of soft tissue sarcoma and colorectal cancer; and NXC-201 for relapsed/refractory multiple myeloma. It has a clinical collaboration and supply agreement with BeiGene Ltd. for a combination Phase 1b clinical trial in solid tumors of IMX-110 and anti-PD-1 Tislelizumab. Immix Biopharma, Inc., was incorporated in 2012 and is headquartered in Los Angeles, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":-0.035123},{"month":2,"riseRate":0.2,"avgChangeRate":-0.05746},{"month":3,"riseRate":0.2,"avgChangeRate":-0.065433},{"month":4,"riseRate":0.4,"avgChangeRate":-0.025442},{"month":5,"riseRate":0.6,"avgChangeRate":0.091547},{"month":6,"riseRate":0.6,"avgChangeRate":0.103039},{"month":7,"riseRate":0.4,"avgChangeRate":-0.025858},{"month":8,"riseRate":0.4,"avgChangeRate":0.053526},{"month":9,"riseRate":0.2,"avgChangeRate":-0.008301},{"month":10,"riseRate":0.75,"avgChangeRate":0.171445},{"month":11,"riseRate":1,"avgChangeRate":0.264693},{"month":12,"riseRate":1,"avgChangeRate":0.380003}],"exchange":"NASDAQ","name":"Immix Biopharma, Inc.","nameEN":"Immix Biopharma, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Immix Biopharma, Inc.(IMMX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Immix Biopharma, Inc.(IMMX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Immix Biopharma, Inc.,IMMX,Immix Biopharma, Inc.股票,Immix Biopharma, Inc.股票老虎,Immix Biopharma, Inc.股票老虎国际,Immix Biopharma, Inc.行情,Immix Biopharma, Inc.股票行情,Immix Biopharma, Inc.股价,Immix Biopharma, Inc.股市,Immix Biopharma, Inc.股票价格,Immix Biopharma, Inc.股票交易,Immix Biopharma, Inc.股票购买,Immix Biopharma, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Immix Biopharma, Inc.(IMMX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Immix Biopharma, Inc.(IMMX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}